{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:04:37Z","timestamp":1760853877717},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","nucmedbio.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.nucmedbio.2016.04.004","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T17:52:26Z","timestamp":1461779546000},"page":"445-453","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [18F]FEDAC: Prerequisites for clinical application"],"prefix":"10.1016","volume":"43","author":[{"given":"Kazunori","family":"Kawamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsushi","family":"Kumata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Takei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Furutsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehito","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Fujishiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoteru","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joji","family":"Yui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Hatori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyoshi","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Fujibayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","article-title":"Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function","volume":"27","author":"Papadopoulos","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2010.06.013","article-title":"Regulation of translocator protein 18kDa (TSPO) expression in health and disease states","volume":"327","author":"Batarseh","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2967\/jnumed.110.086629","article-title":"The translocator protein","volume":"52","author":"Scarf","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/BST20150064","article-title":"The 18-kDa mitochondrial translocator protein in gliomas: from the bench to bedside","volume":"43","author":"Janczar","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1042\/BST20150058","article-title":"The methodology of TSPO imaging with positron emission tomography","volume":"43","author":"Turkheimer","year":"2015","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0030","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.2174\/092986709788803150","article-title":"Radiolabelled molecules for imaging the translocator protein (18kDa) using positron emission tomography","volume":"16","author":"Doll\u00e9","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0035","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00259-013-2359-1","article-title":"In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients","volume":"40","author":"Varrone","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0040","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2967\/jnumed.108.060186","article-title":"Quantification of translocator protein (18kDa) in the human brain with PET and a novel radioligand, 18F-PBR06","volume":"50","author":"Fujimura","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0045","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.2967\/jnumed.113.121020","article-title":"Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding","volume":"54","author":"Guo","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0050","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/jcbfm.2011.55","article-title":"Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography","volume":"31","author":"Rusjan","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0055","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2967\/jnumed.115.156083","article-title":"Optimized quantification of translocator protein radioligand 18F-DPA-714 uptake in the brain of genotyped healthy volunteers","volume":"56","author":"Lavisse","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0060","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.bmcl.2009.01.093","article-title":"[18F]FEAC and [18F]FEDAC: two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain","volume":"19","author":"Yanamoto","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.2967\/jnumed.109.072223","article-title":"18F-FEAC and 18F-FEDAC: PET of the monkey brain and imaging of translocator protein (18kDa) in the infarcted rat brain","volume":"51","author":"Yui","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0070","doi-asserted-by":"crossref","first-page":"e45065","DOI":"10.1371\/journal.pone.0045065","article-title":"PET imaging of lung inflammation with [18F]FEDAC, a radioligand for translocator protein (18kDa)","volume":"7","author":"Hatori","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0075","doi-asserted-by":"crossref","first-page":"e86625","DOI":"10.1371\/journal.pone.0086625","article-title":"Visualization of acute liver damage induced by cycloheximide in rats using PET with [18F]FEDAC, a radiotracer for translocator protein (18kDa)","volume":"9","author":"Hatori","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0080","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jhep.2012.07.002","article-title":"Translocator protein (18kDa), a potential molecular imaging biomarker for non-invasively distinguishing non-alcoholic fatty liver disease","volume":"57","author":"Xie","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0085","doi-asserted-by":"crossref","first-page":"17327","DOI":"10.1038\/srep17327","article-title":"Utility of translocator protein (18kDa) as a molecular imaging biomarker to monitor the progression of liver fibrosis","volume":"5","author":"Hatori","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0090","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0969-8043(02)00075-1","article-title":"Development of an automated system for synthesizing 18F-labeled compounds using [18F]fluoroethyl bromide as a synthetic precursor","volume":"57","author":"Zhang","year":"2002","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0095","series-title":"2-aryl-8-oxodihydropurine derivatives, process for producing the same, medical compositions containing the same, and intermediates thereof. PCT int Appl WO99\/28320","article-title":"Dainippon Sumitomo Pharma Co., Ltd., assignee","author":"Murata","year":"1998"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0100","series-title":"Pharmaceuticals containing 2-aryl-8-oxodihydropurine derivatives. Japanese patent P2001-48882A","article-title":"Dainippon Sumitomo Pharma Co., Ltd., assignee","author":"Murata","year":"2001"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0105","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0040-4039(01)02372-3","article-title":"Solvent-free tetrahydropyranylation (THP) of alcohols and phenols and their regeneration by catalytic aluminum chloride hexahydrate","volume":"43","author":"Vasudevan","year":"2002","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0110","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1124\/dmd.112.046342","article-title":"Metabolism and quantification of [18F]DPA-714, a new TSPO positron emission tomography radioligand","volume":"41","author":"Peyronneau","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.nucmedbio.2011.09.006","article-title":"Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: part II: metabolism studies","volume":"39","author":"Peyronneau","year":"2012","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0120","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.nucmedbio.2015.08.006","article-title":"Identification of a major radiometabolite of [11C]PBB3","volume":"42","author":"Hashimoto","year":"2015","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0969-8043(00)00392-4","article-title":"Sensitive measurement of positron emitters eluted from HPLC","volume":"55","author":"Takei","year":"2001","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0130","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/syn.20678","article-title":"Evaluation of N-benzyl-N-[11C]methyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18kDa) radioligand in kainic acid-lesioned rat","volume":"63","author":"Yanamoto","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0135","first-page":"881","article-title":"Relationship between inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction","volume":"92","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0140","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.bjp.0705681","article-title":"Antianxiety and antidepressant-like effects of AC-5216, a novelmitochondrial benzodiazepine receptor ligand","volume":"142","author":"Kita","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/ajcp\/52.3.320","article-title":"Serum lactate dehydrogenase isoenzyme and total lactate dehydrogenase values in health and disease, and clinical evaluation of these tests by means of discriminant analysis","volume":"52","author":"Glick","year":"1969","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3923\/ijcr.2006.383.389","article-title":"Role of serum lactate dehydrogenase as a bio-marker in therapy related hematological malignancies","volume":"2","author":"Mani","year":"2006","journal-title":"Int J Can Res"},{"key":"10.1016\/j.nucmedbio.2016.04.004_bb0155","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.nucmedbio.2010.04.183","article-title":"In vivo imaging and quantitative analysis of TSPO in rat peripheral tissues using small-animal PET with [18F]FEDAC","volume":"37","author":"Yanamoto","year":"2010","journal-title":"Nucl Med Biol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116300610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805116300610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T04:20:26Z","timestamp":1536812426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805116300610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0969805116300610"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.04.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient radiosynthesis and non-clinical safety tests of the TSPO radioprobe [18F]FEDAC: Prerequisites for clinical application","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2016.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}